Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

CEPI criticised for lack of transparency

(2021) Ann Danaiya Usher   LANCET

The COVID-19 Innovation System

(2021) Bhaven N. Sampat et al.   HEALTH AFFAIRS

Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust

(2021) Kamala Thiagarajan   BMJ-British Medical Journal

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

(2021) Michaël Schwarzinger et al.   Lancet Public Health

SARS-CoV-2 Vaccines: Status Report

(2020) Fatima Amanat et al.   IMMUNITY

Planning for a COVID-19 Vaccination Program

(2020) Sarah Schaffer DeRoo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Equitable Distribution of COVID-19 Therapeutics and Vaccines

(2020) Thomas J. Bollyky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adverse Consequences of Rushing a SARS-CoV-2 Vaccine

(2020) Brit Trogen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ensuring global access to COVID-19 vaccines

(2020) Gavin Yamey et al.   LANCET

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

(2020) Patrick Peretti-Watel et al.   LANCET INFECTIOUS DISEASES

Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn

(2020) Philip Ball   NATURE

If a coronavirus vaccine arrives, can the world make enough?

(2020) Roxanne Khamsi   NATURE

The epic battle against coronavirus misinformation and conspiracy theories

(2020) Philip Ball et al.   NATURE

The online competition between pro- and anti-vaccination views

(2020) Neil F. Johnson et al.   NATURE

Innovation Policy and the Market for Vaccines*

(2020) Q Claire Xue et al.   Journal of Law and the Biosciences

COVID-19–Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis

(2020) Md Saiful Islam et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The Development of COVID-19 Vaccines

(2020) Nicole Lurie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Dual Epidemics of COVID-19 and Influenza

(2020) Lawrence O. Gostin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Unwavering Regulatory Safeguards for COVID-19 Vaccines

(2020) Anand Shah et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multivalue ethical framework for fair global allocation of a COVID-19 vaccine

(2020) Yangzi Liu et al.   JOURNAL OF MEDICAL ETHICS

COVID-19 vaccines for all?

(2020) Ann Danaiya Usher   LANCET

Knowledge transfer for large-scale vaccine manufacturing

(2020) W. Nicholson Price et al.   SCIENCE

Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study

(2020) Alexandre de Figueiredo et al.   LANCET

What China’s speedy COVID vaccine deployment means for the pandemic

(2020) David Cyranoski   NATURE

An ethical framework for global vaccine allocation

(2020) Ezekiel J. Emanuel et al.   SCIENCE

National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020

(2020) Peter G. Szilagyi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inside China’s response to COVID

(2020) Flynn Murphy   NATURE

Arab nations first to approve Chinese COVID vaccine — despite lack of public data

(2020) David Cyranoski   NATURE

No-Fault Compensation for Vaccine Injury — The Other Side of Equitable Access to Covid-19 Vaccines

(2020) Sam Halabi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of a Highly Fit SARS-CoV-2 Variant

(2020) Ralph S. Baric   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Establishment of a Cold Chain Capacity of –60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone

(2018) Morrison O Jusu et al.   JOURNAL OF INFECTIOUS DISEASES

Contribution of NIH funding to new drug approvals 2010–2016

(2018) Ekaterina Galkina Cleary et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improving Global Access to New Vaccines: Intellectual Property, Technology Transfer, and Regulatory Pathways

(2018) Sara Eve Crager   AMERICAN JOURNAL OF PUBLIC HEALTH

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

(2017) Emilie Karafillakis et al.   VACCINE

Immunisation timeliness in a cohort of urban Aboriginal and Torres Strait Islander children

(2016) Yolanda G. Lovie-Toon et al.   BMC PUBLIC HEALTH

Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries

(2016) Niamh Herlihy et al.   HEALTH AFFAIRS

Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008–2013

(2016) Shannon E. MacDonald et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization

(2016) Vincent Ahonkhai et al.   PLoS One

Vaccine hesitancy among healthcare workers in Europe: A qualitative study

(2016) Emilie Karafillakis et al.   VACCINE

The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey

(2016) Heidi J. Larson et al.   EBioMedicine

Strategies for addressing vaccine hesitancy – A systematic review

(2015) Caitlin Jarrett et al.   VACCINE

Strategies intended to address vaccine hesitancy: Review of published reviews

(2015) Eve Dubé et al.   VACCINE

Vaccine hesitancy: Definition, scope and determinants

(2015) Noni E. MacDonald   VACCINE

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012

(2014) Heidi J. Larson et al.   VACCINE

Risk in Vaccine Research and Development Quantified

(2013) Esther S. Pronker et al.   PLoS One

Racial and Ethnic Disparities in Uptake and Location of Vaccination for 2009-H1N1 and Seasonal Influenza

(2011) Lori Uscher-Pines et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Addressing the vaccine confidence gap

(2011) Heidi J Larson et al.   LANCET

Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline

(2011) Matthew M. Davis et al.   VACCINE

Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31

(2010) Robert Hecht et al.   LANCET

Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1

(2010) David P. Fidler   PLOS MEDICINE

Poverty, Wealth, and Access to Pandemic Influenza Vaccines

(2009) Tadataka Yamada   NEW ENGLAND JOURNAL OF MEDICINE